Close Menu

NEW YORK – Accelerate Diagnostics reported after the close of the market on Thursday that its third quarter revenues jumped 64 percent year over year.

It missed the consensus Wall Street estimate, however, and blamed an elongated sales cycle and the timing of commercial go-lives during the quarter for the lower-than-expected top line results.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.